Common Contracts

EX-10.1 2 drna-ex101_125.htm EX-10.1 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under

Confidential Settlement Agreement and General Release • May 5th, 2020 • Massachusetts

• Contract Type
  Confidential Settlement Agreement and General Release
• Filed
  May 5th, 2020
• Jurisdiction
  Massachusetts

CONFIDENTIAL SETTLEMENT AGREEMENT AND GENERAL RELEASE

Confidential Settlement Agreement and General Release • August 8th, 2018 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts

• Contract Type
  Confidential Settlement Agreement and General Release
• Filed
  August 8th, 2018
• Company
  Dicerna Pharmaceuticals Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Massachusetts

This Settlement Agreement and General Release (the “Agreement”) is entered into this 18th day of April 2018 (the “Effective Date”) by and among Alnylam Pharmaceuticals, Inc., a Delaware corporation with a principal place of business at 300 Third Street, Cambridge, MA 02142 (“Alnylam”), and Dicerna Pharmaceuticals, Inc., a Delaware corporation with a principal place of business at 87 Cambridgepark Drive, Cambridge, MA 02140 (“Dicerna”). Each of Alnylam and Dicerna shall be considered a “Party,” and collectively they shall be considered the “Parties.”